nVerses Capital’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,500
Closed -$17.3K 951
2024
Q3
$17.3K Sell
1,500
-1,100
-42% -$12.6K 0.01% 824
2024
Q2
$29.4K Sell
2,600
-11,100
-81% -$148K 0.02% 697
2024
Q1
$196K Buy
+13,700
New +$194K 0.47% 34

Other funds holding PTVE

nVerses Capital's PTVE Position: Q4 2024 in Review

nVerses Capital sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q4 2024, closing a stake of 1,500 shares — an estimated $17.3K sold.

nVerses Capital first reported a position in PTVE in Q1 2024 and held it in 3 quarters. The position peaked at $196K in Q1 2024. 161 funds tracked by Wall St. Rank hold PTVE as of Q4 2024.

  • nVerses Capital reported no remaining Pactiv Evergreen Inc. Common stock position as of Q4 2024 after selling out during the quarter.
  • nVerses Capital sold 1,500 Pactiv Evergreen Inc. Common stock shares in Q4 2024, an estimated $17.3K.
  • nVerses Capital first reported a position in Pactiv Evergreen Inc. Common stock in Q1 2024 and held it in 3 quarters.
  • nVerses Capital's Pactiv Evergreen Inc. Common stock position peaked at $196K in Q1 2024.
  • 161 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.